Single-use device reuse
This article was originally published in The Gray Sheet
House-Senate conferees agree to language in the FY 2000 agriculture appropriations bill that would require FDA to allocate $1 mil. to study the reprocessing of single-use medical devices, conferee Sen. Richard Durbin (D-Ill.) reports Sept. 23. The provision was a part of the Senate ag approps measure but Durbin notes that conferees opted to use language from his stand-alone bill (S 1542), the "Reprocessed Single Use Medical Device Patient Safety Amendments," rather than what originally had been proposed. The conference committee has also agreed to set FDA appropriations at approximately $1.19 bil. -below the level approved by the House but above that passed by the Senate. The conference committee has stood in recess since Sept. 22, stalled by disagreements over agricultural issues. No date has been set for resuming the conference
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Commissioner Hahn’s tweet announcing a return to inspections, while not a new policy, may be signal that FDA understands sponsor concerns with the agency’s limited ability to conduct onsite inspections. Effort may be aimed at reassuring industry even as CRLs related to manufacturing increase.
Rushed final rule seeking to impose draconian cuts on drug reimbursement rates in the Medicare Part B program is certain to face legal and political obstacles. But the data included on international price benchmarks will still have an impact.